Eisai Co Ltd Launch of LEQEMBI in Japan Transcript

Dec 13, 2023 / 07:00AM GMT
Unidentified Company Representative -

Thank you very much for taking your time to attend the conference today. It is now time. We would now like to begin media investor conference for the launch of LEQEMBI in Japan. This is a hybrid presentation, both in person here as well as with attendance online. Those of you who are attending in person, please find the press release. Those of you who are participating online, you are able to download the press release from the chat box. There are English and Japanese versions available.

I would now like to introduce the presenter Mr. Haruo Naito, Representative Corporate Officer and CEO. Mr. Naito, CEO, please.

Haruo Naito - Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director

Thank you. At Chuikyou, Central Social Insurance Medical Council, drug price and Optimal Clinical Use Guidelines were approved. On this occasion, regarding the launch of LEQEMBI, we would like to share with you our thinking. Please refer to the material distributed to you as I will be discussing in line with that material. At its

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot